TSX:WELL - Post Discussion
Post by
Smokey1958 on Nov 15, 2023 3:04pm
Growth Organically and Inorganically
* Current portfolio represents organic growth.
* Inorganic growth involves acquisitions.
Management is pleased to provide the following update to its revenue guidance, which only includes announced acquisitions:
* Annual revenue for 2023 is expected to be in the range of $755 million to $765 million.
* Annual revenue for 2024 is expected to be over $900 million.
WELL expects to continue to grow its industry leading Canadian Patient Services business both organically and inorganically and enhance its market leadership as the country's first pan-Canadian clinical network with a highly integrated network of tech-enabled outpatient healthcare clinics across the country. Meanwhile, growth in the Company's WELL Health USA Patient Services business is expected to be primarily driven by organic growth, augmented by the Company's recent acquisition of CarePlus.
Be the first to comment on this post